Article Versions Notes

Brandi A, de Faria Lainetti P, Elias F, Rodrigues MMP, Fagundes Moraes L, Laufer-Amorim R, de Camargo LS, Salles Gomes CdOM, Fonseca-Alves CE. Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors. Animals. 2023; 13(1):60. https://doi.org/10.3390/ani13010060

Brandi, Andressa, Patricia de Faria Lainetti, Fabiana Elias, Marcela Marcondes Pinto Rodrigues, Livia Fagundes Moraes, Renée Laufer-Amorim, Laíza Sartori de Camargo, Cristina de Oliveira Massoco Salles Gomes, and Carlos Eduardo Fonseca-Alves. 2023. "Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors" Animals 13, no. 1: 60. https://doi.org/10.3390/ani13010060

Brandi, A., de Faria Lainetti, P., Elias, F., Rodrigues, M. M. P., Fagundes Moraes, L., Laufer-Amorim, R., de Camargo, L. S., Salles Gomes, C. d. O. M., & Fonseca-Alves, C. E. (2023). Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors. Animals, 13(1), 60. https://doi.org/10.3390/ani13010060